NCT05875285 is a NA clinical trial of Iontophoresis with methotrexate in Hyperhidrosis, sponsored by Cairo University.

Who is sponsoring NCT05875285?

NCT05875285 is sponsored by Cairo University.

What drugs are being tested in NCT05875285?

Interventions in NCT05875285: Iontophoresis with methotrexate, Iontophoresis with coal tar ointement.

What condition does NCT05875285 study?

NCT05875285 studies Hyperhidrosis, Iontophore.

Is NCT05875285 still recruiting?

NCT05875285 is currently status unknown. Last updated 25 May 2023.

Last reviewed 2023-05-25 · How we verify

NCT05875285

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis

Status unknown NA Last updated 25 May 2023

What this trial tests

NA trial testing Iontophoresis with methotrexate in Hyperhidrosis in 60 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
20 August 2023

1 October 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	1 June 2023
Primary completion	20 August 2023
Estimated completion	1 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

Iontophoresis with methotrexate
Iontophoresis with coal tar ointement

Conditions studied

Hyperhidrosis — all drugs for Hyperhidrosis →
Iontophore — all drugs for Iontophore →

Sponsor

Cairo University

Who can join

Adults 15 to 35, any sex, with Hyperhidrosis or Iontophore. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to compare the therapeutic effect of methotrexate iontophoresis versus coal tar ointment on the the treatment of primary palmer hyperhidrosis?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hyperhidrosis

Currently open trials in the same condition.

NCT05805696 — Treatment and Mapping of Impostor Phenomenon · NA · recruiting
NCT05102396 — Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? · Phase 2 · recruiting
NCT05403710 — Botulinum Toxin Therapy in Hidradenitis Suppurativa · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05875285 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 25 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05875285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing